our services span the entire lifecycle of product
development and commercialisation, and can be adapted to
suit small local trials or large global programs.
site and patient identification, enrolment and engagement.
integrated services that cover planning, management, execution and analysis.
乐和彩开户icon provides its full range of clinical, consulting and commercial services across several industry sectors.
the new eu medical and in vitro diagnostic device regulations go into effect at the start of 2020. are you ready?
strategies and recommendations to achieve optimal market access.
乐和彩开户we have extensive experience in a broad range of therapeutic areas. managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.
乐和彩开户icon has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with car-t therapies.
icon has recently led the development of 17 vaccines resulting in fda/ema approvals.
乐和彩开户we develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs.
乐和彩开户using data to design, simulate, and analyse adaptive clinical trials with ease.
connecting patients with the right trial in the right location.
乐和彩开户biopharma companies and medical devices manufacturers face growing operational, regulatory and economic challenges. icon provides analysis and key insights on these challenges, with practical advice and recommendations.
remote monitoring and leveraging wearable devices and sensors in clinical trials.
reduce post market study costs with real world data.
icon regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading contract research organisations through a number of high-profile industry awards.
12 march, 2020
乐和彩开户6 - 9 april, 2020
乐和彩开户our mission is to help clients accelerate the development of
drugs and devices that save lives and improve quality of life.
乐和彩开户we are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
partners making a difference.
乐和彩开户acquisition expands icon’s global medical device and diagnostic research services
乐和彩开户 full-service providers at the 15th annual scrip awards 2019
乐和彩开户offering customers hybrid trial solutions and site support services
乐和彩开户acquisition enhances icon’s patient access in europe and africa